Research ArticleBasic Science Investigations
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-18F-Fluorothymidine PET and Diffusion-Weighted MR Imaging
Sonja Schelhaas, Lydia Wachsmuth, Thomas Viel, Davina J. Honess, Kathrin Heinzmann, Donna-Michelle Smith, Sven Hermann, Stefan Wagner, Michael T. Kuhlmann, Carsten Müller-Tidow, Klaus Kopka, Otmar Schober, Michael Schäfers, Richard Schneider, Eric O. Aboagye, John Griffiths, Cornelius Faber and Andreas H. Jacobs
Journal of Nuclear Medicine June 2014, 55 (6) 983-988; DOI: https://doi.org/10.2967/jnumed.113.133348
Sonja Schelhaas
1European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany
Lydia Wachsmuth
2Department of Clinical Radiology, University Hospital of Münster, Münster, Germany
Thomas Viel
1European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany
Davina J. Honess
3Cancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom
Kathrin Heinzmann
3Cancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom
Donna-Michelle Smith
3Cancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom
Sven Hermann
1European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany
Stefan Wagner
4Department of Nuclear Medicine, University Hospital of Münster, Münster, Germany
Michael T. Kuhlmann
1European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany
Carsten Müller-Tidow
5Department of Hematology and Oncology, University Hospital of Münster, Münster, Germany
Klaus Kopka
4Department of Nuclear Medicine, University Hospital of Münster, Münster, Germany
Otmar Schober
1European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany
4Department of Nuclear Medicine, University Hospital of Münster, Münster, Germany
Michael Schäfers
1European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany
4Department of Nuclear Medicine, University Hospital of Münster, Münster, Germany
Richard Schneider
6Merck Serono, Darmstadt, Germany
Eric O. Aboagye
7Comprehensive Cancer Imaging Centre, Imperial College London, London, United Kingdom; and
John Griffiths
3Cancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom
Cornelius Faber
2Department of Clinical Radiology, University Hospital of Münster, Münster, Germany
Andreas H. Jacobs
1European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms-Universität (WWU) Münster, Münster, Germany
8Department of Geriatric Medicine, Johanniter Hospital, Bonn, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 6
June 1, 2014
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-18F-Fluorothymidine PET and Diffusion-Weighted MR Imaging
Sonja Schelhaas, Lydia Wachsmuth, Thomas Viel, Davina J. Honess, Kathrin Heinzmann, Donna-Michelle Smith, Sven Hermann, Stefan Wagner, Michael T. Kuhlmann, Carsten Müller-Tidow, Klaus Kopka, Otmar Schober, Michael Schäfers, Richard Schneider, Eric O. Aboagye, John Griffiths, Cornelius Faber, Andreas H. Jacobs
Journal of Nuclear Medicine Jun 2014, 55 (6) 983-988; DOI: 10.2967/jnumed.113.133348
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-18F-Fluorothymidine PET and Diffusion-Weighted MR Imaging
Sonja Schelhaas, Lydia Wachsmuth, Thomas Viel, Davina J. Honess, Kathrin Heinzmann, Donna-Michelle Smith, Sven Hermann, Stefan Wagner, Michael T. Kuhlmann, Carsten Müller-Tidow, Klaus Kopka, Otmar Schober, Michael Schäfers, Richard Schneider, Eric O. Aboagye, John Griffiths, Cornelius Faber, Andreas H. Jacobs
Journal of Nuclear Medicine Jun 2014, 55 (6) 983-988; DOI: 10.2967/jnumed.113.133348
Jump to section
Related Articles
Cited By...
- Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'-18F-Fluorothymidine Uptake After Therapy in a Colorectal Cancer Model
- Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer
- Preclinical Evidence That 3'-Deoxy-3'-[18F]Fluorothymidine PET Can Visualize Recovery of Hematopoiesis after Gemcitabine Chemotherapy